{"id":"W4206922330","doi":"10.1200/jco.2022.40.36_suppl.359881","title":"INTRIGUE: A phase III, randomized, open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Deciphera Pharmaceuticals","keywords":"Medicine; Sunitinib; GiST; Imatinib; Internal medicine; Clinical endpoint; Population; Imatinib mesylate; Interim analysis; Oncology; Randomization; Tyrosine-kinase inhibitor; Gastroenterology; Surgery; Randomized controlled trial; Cancer; Stromal cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001910175,0.001463093,0.002561935,0.0003003957,0.0004521518,0.001129995,0.0009116078,0.001336569,0.007719352],"category_scores_gemma":[0.001565328,0.0005357732,0.002013069,0.0003196854,0.001203609,0.001374831,0.0005046899,0.003238976,0.001090725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000934792,"about_ca_system_score_gemma":0.001438131,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006120976,"about_ca_topic_score_gemma":0.002342045,"domain_scores_codex":[0.9993205,0.0003795474,0.00003422554,0.0001216813,0.00004475541,0.00009927054],"domain_scores_gemma":[0.9989504,0.0002345645,0.000246484,0.00008103767,0.00005430369,0.0004332324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9637653,0.01223974,0.001855249,0.000398497,0.00119232,0.00006114122,0.00007936112,0.0004903822,0.004172914,0.0001249037,0.001224086,0.01439622],"study_design_scores_gemma":[0.8860855,0.1087127,0.003230468,0.00001253441,0.0003707597,0.00005187571,0.00002945147,0.0004349479,0.0002375293,0.0001674428,0.0006527122,0.00001398471],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989104,0.002186804,0.0006893757,0.0007631796,0.0002946429,0.003464698,0.001435147,0.0001335177,0.001928677],"genre_scores_gemma":[0.9868652,0.000951165,0.001690509,0.001810909,0.0003322756,0.004706813,0.001610114,0.00003471852,0.001998344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007719352,"threshold_uncertainty_score":0.02582377,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09788494523111237,"score_gpt":0.4694314721276791,"score_spread":0.3715465268965667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}